oncoFISH Cervical Test for Detection of 3q26 Region Gain

Ikonisys, Inc.1,100 enrolled

Overview

The purpose of this study is to evaluate the use of the oncoFISH cervical test system in the management of women who have received an LSIL Pap report to determine whether the test can predict which women will progress to more serious cervical disease and which women do not have to be monitored as closely.

Study Type

OBSERVATIONAL

Enrollment

1,100

Conditions

Cervical Cancer LSIL

Eligibility

Sex: FEMALEMin age: 21 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * Women 21 years of age or greater with recent LSIL who are scheduled for colposcipal assessment. * Women with previous or current STD or HIV may be included * Women with previous LSIL history may be included. Exclusion Criteria: * pregnant women, * women with vaginal intraepithelial lesions, * women on a chemotherapeutic agent, * women with previous or current cancer except for non-cervical squamous cell carcinoma

Locations (1)

Ikonisys

New Haven, Connecticut, United States

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.